IMA970A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMA970A, covering 2020-02-05 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) [Phase 1]